Workflow
Architectural Design Services
icon
Search documents
OFA Group(OFAL) - Prospectus(update)
2025-09-26 20:10
As filed with the U.S. Securities and Exchange Commission on September 26, 2025. Registration No. 333-289618 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OFA Group (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) ...
OFA Group Signs Non-Binding Letter of Intent to Acquire Controlling Stake in Aspire Homes and RateDNA
Globenewswire· 2025-06-27 12:08
Core Insights - OFA Group has signed a Letter of Intent to acquire a 60% controlling interest in Aspire Homes Realty Inc. and its affiliated lending platform, RateDNA, Inc. [1] - The acquisition aims to expand OFA's presence in the resilient sectors of real estate services and specialty lending [4] Company Overview - OFA Group is an integrated architecture and technology firm that provides comprehensive architectural services, including design and fit-out services for commercial and residential buildings [5] - The company is focused on leveraging its architectural design expertise and developing proprietary AI technologies to enhance its services [5] Acquisition Details - RateDNA is a high-growth, vertically integrated real estate and mortgage business backed by AlphaX, serving both residential clients and real estate investors [2] - Aspire Homes offers brokerage services with investment-focused agent training and in-house staging, design, and construction, while RateDNA provides mortgage products tailored to the investor market [3] Strategic Rationale - The COO of OFA Group believes the acquisition represents a compelling opportunity to leverage operational talent to accelerate revenue and enhance cross-platform synergies [4] - The integration of Aspire and RateDNA is expected to create meaningful potential for long-term shareholder value creation [4]